Gwee Jo-Ee hopes to raise awareness about suicide prevention by becoming the first woman to swim from Pulau Redang to Pulau ...

The days are getting shorter as we "fall back” into standard time and it may be affecting your mood. While we settle into our ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Seasonal Affective Disorder (SAD) affects millions of Americans, and cases usually start to rise in late fall or early winter ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

The following is a summary of “Voice of depression: speech features as biomarkers for major depressive disorder,” published ...

Cybin (TSE:CYBN) has released an update. Cybin Inc. is set to unveil promising 12-month Phase 2 data for CYB003 in treating Major Depressive ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

The firm expects to report its 12-month phase 2 data next week, with topline results from a phase 3 trial anticipated in 2026 ...

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulation. Single-Ascending Dosing (SAD) study to evaluate safety and pharmacokinetics in obese and normal weight ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...